✦ LIBER ✦

Should British soldiers be vaccinated against hepatitis A? An economic analysis

✍ Scribed by T.O. Jefferson; R.H. Behrens; V. Demicheli

Book ID: 119152083
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 486 KB
Volume: 12
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(94)90145-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should adolescents be vaccinated against

Should adolescents be vaccinated against hepatitis A: the Hong Kong experience

✍ A. Lee; F. Cheng; L. Lau; A. Lo; W.E. Fabb 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Should Brazilian patients with chronic h

Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?

✍ Livia M Villar; Maria MM De Melo; Izabelle A Calado; Adilson J De Almeida; Elisa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

New vaccines against hepatitis a enter t

New vaccines against hepatitis a enter the market — But who should be vaccinated?

✍ S. Iwarson 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 299 KB

Vaccination Strategies Against Hepatitis

Vaccination Strategies Against Hepatitis A in Travelers Older Than 40 Years: An Economic Evaluation

✍ Laura Costas; Anna Vilella; Antoni Trilla; Beatriz Serrano; Isabel Vera; Montse 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB

Universal mass vaccination against varic

Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: An economic analysis

✍ Thomas Hammerschmidt; Helmtrud Bisanz; Peter Wutzler 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 596 KB

An economic analysis of different strate

An economic analysis of different strategies of immunization against hepatitis a virus in developed countries

✍ Ananya Das 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Acute hepatitis A is a major public health problem in developed countries, and because a large proportion of patients with acute hepatitis A do not have any identifiable risk factors, current practice of targeting the high-risk groups for vaccination against hepatitis A virus (HAV) is unlikely to ha